Evidence map›Paper›PMID 35929810›Full record

ArticleTransactions of the Royal Society of Tropical Medicine and Hygiene2023

Clinical and epidemiological aspects of severe acute respiratory infection: before and during the first year of the COVID-19 pandemic in Brazil.

Felipe Cotrim de Carvalho, Erica Tatiane da Silva, Walquiria Aparecida Ferreira de Almeida, Matheus Almeida Maroneze, Jaqueline de Araujo Schwartz, João Pedro Vieira Jardim, Henry Maia Peixoto

Abstract read
In one paragraph

Article in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Costs of hospital admissions due to COVID-19 in the federal capital of Brazil: a study based on hospital admission authorizations.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
  9. Hospitalization costs of patients with severe acute respiratory infections due to COVID-19 in a public teaching hospital: a micro-costing approach.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Felipe Cotrim de CarvalhoCenter of Tropical Medicine, Faculty of Medicine, University of Brasilia, Brasilia, Brazil.
Erica Tatiane da SilvaEvidence Program for Health Policies and Technologies, Oswaldo Cruz Foundation, Brasilia, Federal District, Brazil.
Walquiria Aparecida Ferreira de AlmeidaSurveillance Secretariat in Health, Ministry of Health, Brasília, Federal District, Brazil.
Matheus Almeida MaronezeSurveillance Secretariat in Health, Ministry of Health, Brasília, Federal District, Brazil.
Jaqueline de Araujo SchwartzSurveillance Secretariat in Health, Ministry of Health, Brasília, Federal District, Brazil.
João Pedro Vieira JardimCenter of Tropical Medicine, Faculty of Medicine, University of Brasilia, Brasilia, Brazil.
Henry Maia PeixotoCenter of Tropical Medicine, Faculty of Medicine, University of Brasilia, Brasilia, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWidespread respiratory infections with high morbidity rates caused by respiratory viruses represent a significant global public health problem. Our objective was to describe cases and deaths from severe acute respiratory infection (SARI) in Brazil over the past 8 y as well as changes in the distribution and risk of illness and death from SARI before and in the first year of the coronavirus disease 2019 (COVID-19) pandemic (FYP).

methodsWe performed a descriptive epidemiological study of hospitalized SARI cases and deaths between 2013 and 2020 in Brazil, separated into pre-pandemic (2013 to 2019) and FYP (2020). We estimate the increase in SARI cases and deaths in the FYP as well as the mortality and infection risks attributable to the FYP (MRAP and IRAP, respectively).

resultsIn 2020, an excess of 425 054 cases and 109 682 deaths was observed, with a significant increase in the risk of falling ill and dying from SARI, with an IRAP of 200.06 and an MRAP of 51.68 cases per 100 000 inhabitants. The increase in SARI cases and deaths was particularly prominent among patients with COVID-19, the elderly, males, those self-identifying as mixed race and patients with heart disease and diabetes. We conclude that an important increase in morbidity and mortality due to SARI was observed in the FYP. More vulnerable groups and those living in the Southeast, North and Center-West regions of the country suffered the most.

Indexed as

COVID-19Influenza, HumanRespiratory Tract InfectionsAgedBrazilHospitalizationHumansInfantMalePandemicsCOVID-19hospitalizationsinfluenzarespiratory syncytial virusSARI

Identifiers

PMID35929810
PMCPMC9384673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.